EDGAR Filing Documents for 0001387131-13-003094

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001387131-13-003094

Filing Date

2013-08-19

Accepted

2013-08-19 15:59:53

Documents

Period of Report

2013-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	admp-10q_063013.htm	10-Q	452999
2	CERTIFICATION OF CHIEF EXECUTIVE OFFICER	ex31_1.htm	EX-31.1	17624
3	CERTIFICATION OF VICE PRESIDENT, FINANCE AND CHIEF FINANCIAL OFFICER	ex31_2.htm	EX-31.2	18122
4	CERFICATION OF CHIEF EXECUTIVE OFFICER	ex32_1.htm	EX-32.1	8174
5	CERTIFICATION OF VICE PRESIDENT, FINANCE AND CHIEF FINANCIAL OFFICER	ex32_2.htm	EX-32.2	7820
	Complete submission text file	0001387131-13-003094.txt		4165775

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	admp-20130630.xml	EX-101.INS	378987
7	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	admp-20130630.xsd	EX-101.SCH	27514
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	admp-20130630_cal.xml	EX-101.CAL	31897
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	admp-20130630_def.xml	EX-101.DEF	82270
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	admp-20130630_lab.xml	EX-101.LAB	196305
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	admp-20130630_pre.xml	EX-101.PRE	141692

Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130

Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400

Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)